Cargando…

Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study

BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Abikshyeet, Bandyopadhyay, Alokenath, Mohiddin, Gouse, Raghuvanshi, Malvika, Sahoo, Sanjay Kumar, Bhuyan, Lipsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771186/
https://www.ncbi.nlm.nih.gov/pubmed/31579378
http://dx.doi.org/10.4103/njs.NJS_17_18
_version_ 1783455644668395520
author Panda, Abikshyeet
Bandyopadhyay, Alokenath
Mohiddin, Gouse
Raghuvanshi, Malvika
Sahoo, Sanjay Kumar
Bhuyan, Lipsa
author_facet Panda, Abikshyeet
Bandyopadhyay, Alokenath
Mohiddin, Gouse
Raghuvanshi, Malvika
Sahoo, Sanjay Kumar
Bhuyan, Lipsa
author_sort Panda, Abikshyeet
collection PubMed
description BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immunohistochemistry and to describe the relationship between increased metabolic status and the grades of OSCC. MATERIALS AND METHODS: This is cross-sectional study with 76 formalin-fixed paraffin-embedded tissue blocks of OSCC, obtained from the archives of the department. All the cases were scored using Bryne's grading system by three oral pathologists independently. The tissue sections were then stained using immunohistochemistry with anti-GLUT-1 rabbit monoclonal antibody. RESULTS: Staining intensity and localization of positively stained slides were evaluated. Overall, a significant correlation between Bryne's histopathological grading system for OSCC and GLUT-1 immunohistochemical expression was observed. Thus, high GLUT-1 expressions are observed with increasing grades of OSCC. CONCLUSION: This study shows that a significant positive correlation exists between GLUT-1 immunoexpression and histological grading of OSCC. Thus, GLUT-1 expression can be used as a diagnostic adjunct and prognostic marker for OSCC patients.
format Online
Article
Text
id pubmed-6771186
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67711862019-10-02 Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study Panda, Abikshyeet Bandyopadhyay, Alokenath Mohiddin, Gouse Raghuvanshi, Malvika Sahoo, Sanjay Kumar Bhuyan, Lipsa Niger J Surg Original Article BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immunohistochemistry and to describe the relationship between increased metabolic status and the grades of OSCC. MATERIALS AND METHODS: This is cross-sectional study with 76 formalin-fixed paraffin-embedded tissue blocks of OSCC, obtained from the archives of the department. All the cases were scored using Bryne's grading system by three oral pathologists independently. The tissue sections were then stained using immunohistochemistry with anti-GLUT-1 rabbit monoclonal antibody. RESULTS: Staining intensity and localization of positively stained slides were evaluated. Overall, a significant correlation between Bryne's histopathological grading system for OSCC and GLUT-1 immunohistochemical expression was observed. Thus, high GLUT-1 expressions are observed with increasing grades of OSCC. CONCLUSION: This study shows that a significant positive correlation exists between GLUT-1 immunoexpression and histological grading of OSCC. Thus, GLUT-1 expression can be used as a diagnostic adjunct and prognostic marker for OSCC patients. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6771186/ /pubmed/31579378 http://dx.doi.org/10.4103/njs.NJS_17_18 Text en Copyright: © 2019 Nigerian Journal of Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Panda, Abikshyeet
Bandyopadhyay, Alokenath
Mohiddin, Gouse
Raghuvanshi, Malvika
Sahoo, Sanjay Kumar
Bhuyan, Lipsa
Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title_full Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title_fullStr Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title_full_unstemmed Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title_short Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
title_sort can increased metabolic status be a grading tool for oral squamous cell carcinoma? a glucose transporter 1 immunoexpression study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771186/
https://www.ncbi.nlm.nih.gov/pubmed/31579378
http://dx.doi.org/10.4103/njs.NJS_17_18
work_keys_str_mv AT pandaabikshyeet canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy
AT bandyopadhyayalokenath canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy
AT mohiddingouse canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy
AT raghuvanshimalvika canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy
AT sahoosanjaykumar canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy
AT bhuyanlipsa canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy